Edge Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$673K Hold
7,895
0.06% 196
2018
Q1
$610K Sell
7,895
-137
-2% -$11K 0.06% 204
2017
Q4
$678K Sell
8,032
-82
-1% -$6.98K 0.07% 194
2017
Q3
$694K Hold
8,114
0.08% 183
2017
Q2
$667K Sell
8,114
-929
-10% -$75.8K 0.08% 187
2017
Q1
$760K Buy
9,043
+880
+11% +$70.5K 0.09% 181
2016
Q4
$600K Buy
+8,163
New +$608K 0.08% 196

Other funds holding LLY

Edge Advisors's LLY Position: Q2 2018 in Review

Edge Advisors held its Eli Lilly (LLY) position steady in Q2 2018 at 7,895 shares worth $673K. The position accounts for 0.06% of the portfolio, ranked #196.

Edge Advisors first reported a position in LLY in Q4 2016 and has held it in 7 quarters since. The position peaked at $760K in Q1 2017. 1,368 funds tracked by Wall St. Rank hold LLY as of Q2 2018.

  • Edge Advisors held 7,895 shares of Eli Lilly worth $673K as of Q2 2018.
  • Edge Advisors left its Eli Lilly share count unchanged in Q2 2018.
  • Eli Lilly made up 0.06% of Edge Advisors's portfolio in Q2 2018, its #196 holding.
  • Edge Advisors first reported a position in Eli Lilly in Q4 2016 and has held it in 7 quarters since.
  • Edge Advisors's Eli Lilly position peaked at $760K in Q1 2017.
  • 1,368 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.